Yiviva
Business Services · 1-10 Employees
View Company Info for Free
Overview
Phone Number
(646) 883-3906Website
www.yiviva.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Yiviva
Yiviva is a clinical stage, platform biotechnology company developing multi-targeted, systems biology therapeutics, focused on cancer and inflammatory diseases. The Yiviva STAR (signal transduction, activity and response) discovery platform accelerates the identification of botanical therapeutics that influence immune function, inflammatory responses, cell growth and metabolic functions and hormone activity. Yiviva applies patented, mechanism-based quality control linked to biological activity to satisfy established regulatory requirements for complex products.Explore more
Yiviva Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Yiviva your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Yiviva has recently received funding, and reach out quickly before it becomes old news!
Click to see if Yiviva had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Yiviva
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Yiviva is spiking on competitors!
Product Launch: Get notified when Yiviva launches new products
Funding: Get notified immidiatlly once Yiviva has new funding data
Yiviva, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Yiviva recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Yiviva as Masked Content
Find more new buyers
Compare Similar Companies to Yiviva
Compare insights from companies similar to Yiviva, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Yiviva is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Yiviva is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Yiviva.
Yiviva Tech Stack
A closer look at the technologies used by Yiviva
Yiviva News & Media
Preclinical Immunotherapy Research Featured in Poster Presentation at AACR 2022 Annual Meeting Highlights YIV-906’s Immunomodulatory Mechanisms in Combination with Immune Checkpoint or CAR T Therapy
YIV-906 is a botanical cancer drug Scutellaria baicalensis is one of four components of the cancer drug YIV-906 and found to play a key role in immunomodulation in the tumor microenvironment. - First-in-class oncology therapeutic candidate YIV-906 applies an integrative systems biology approach to turn cold tumors hot - YIV-906 could increase therapeutic index for immunotherapies and become platform for cancer regimens NEW HAVEN, Conn and NEW YORK and SHANGHAI, April 08, 2022 (GLOBE NEWSWIRE)Yiviva Wins 2 Top Awards at SAPA Investment Forum and Road Show for Innovative Systems Biology Approach to Treat Cancer
NEW YORK and SHANGHAI, China, July 30, 2021 (GLOBE NEWSWIRE) -- Yiviva, a clinical-stage biotechnology company that uses a systems-biology approach to treat aging-associated diseases, won two top awards at the 4th annual Sino-American Pharmaceutical Professionals Association (SAPA) Investment Forum and Road Show. The Yiviva team presented their innovative approach to advancing cancer treatment through a first-in-class immune system modulator called YIV-906 to a panel of top investors and pharmacYiviva Announces Dosing of First Patient in Phase 2b Study of First-Line YIV-906 Plus Sorafenib Combination Therapy in the Treatment of Hepatocellular Carcinoma
- First-in-class oncology therapeutic candidate YIV-906 applies an integrative systems biology approach - - Global study to evaluate efficacy, safety, and quality of life in patients with hepatitis B-positive hepatocellular carcinoma -
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Yiviva
Sign Up For FreeTo access detailed company insights
Yiviva is a clinical stage, platform biotechnology company developing multi-targeted, systems biology therapeutics, focused on cancer and inflammatory diseases. The Yiviva STAR (signal transduction, activity and response) discovery platform accelerates the identification of botanical therapeutics that influence immune function, inflammatory respons... Read More
